Ross Rheingans-Yoo

Development and Research

Science EN ↓ 6 epizód

The clinical trials process is broken. It is unbelievably expensive and slow: it takes more than ten years and a billion dollars to get a typical drug approved. Join Ross Rheingans-Yoo on Development & Research—a new video series on fixing drug development, with new episodes on some Tuesdays.

Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: developmentandresearch.bio

Szerző

Ross Rheingans-Yoo

Kategória

Science

A podcast weboldala

developmentandresearch.bio

Legutóbbi epizód

2025. aug. 20.

Hol hallgathatod?

Podcastok az alkalmazásban Replaio Radio Hamarosan

A podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz

Letöltés a Google Play-ről Telepítsd ingyen Android közel 10 M letöltés · 4,8-as értékelés iOS hamarosan

Epizódok

Drugs that work for everyone — with Mark Dybul 20.08.2025

When the CEO of Walmart explained why his company was partnering with a U.S. global AIDS program, he didn't mention humanitarian concerns. He said Walmart couldn’t make its ten-year growth projections without a healthy, economically growing Africa—because a sick continent disrupted supply chains and eliminated future customers. I’m joined this week by  Ambassador Mark Dybul , one of the architects...

Fighting bacteria with viruses — with Jessica Sacher 31.07.2025

Don't look now, but there are bacteriophages on your shoes. And if you scraped off a sample and sent them to a phage biology lab, one strain of them might turn out to be a natural, targeted predator for an antibiotic-resistant bacterial infection that a surgery patient has been fighting for the past year. I'm joined this week by Jessica Sacher , a Stanford phage biologist, cofounder of Pha...

Can public health make a profit? — with Charlie Petty 31.07.2025

Most venture capitalists avoid infectious disease because the sickest patients live in countries that can't pay for expensive medicine—and because a one-time treatment can charge only a fraction of what a lifetime chronic drug can. Then again, one-time treatments for patients aged 18-30 in the developing world can be 10× to 100× cheaper to study than the Big Pharma playbook would have you beli...

Drugs Cheaper Than Beer — with Brian Finrow 24.06.2025

I'm joined this week by Brian Finrow , CEO of Lumen Bioscience , who thinks we would be better off if we grew more drugs in algae, and fewer in Chinese Hamster Ovary cells. We talk about why "monoclonal antibodies" are particularly safe and effective as drugs—but incredibly expensive to manufacture—and whether the fundamental problem of the biotech industry is that everyone just has...

How (not) to waste a billion dollars (on your clinical trial) — with Meri Beckwith 20.05.2025

I'm joined this week by Meri Beckwith , who founded  Lindus Health  after being a clinical trial patient—because he was astounded at how badly clinical drug trials were being run by the world's leading companies. We talk about why clinical trials companies are twenty years behind in adopting new technologies, how a flooded supply closet can cause a billion-dollar clinical trial to fail, an...

Development And Research Trailer 08.05.2025

Development & Research is a video series about doing things differently in the world of clinical trials. Development and Research is produced by Samuel Cottrell (hath.blog) Thank you to Michael Curzi at Hallsong Media (hallsong.com) for producing the trailer.

Hallgasd a(z) Development and Research podcastot a Replaióban

Rádió és podcastok egy alkalmazásban - ingyen és regisztráció nélkül. Telepítsd még ma, és ne maradj le a premierről

Letöltés a Google Play-ről

A Replaio nem podcastkiadó; a műsorok nevei, borítóképei és hanganyagai a szerzőiket illetik, és nyilvános RSS-csatornákon keresztül terjednek.